The Curbside · Stop 01 · Hepatology
Reading liver function tests in three questions.
Framework adapted from Dr. M. Shujat Rasool. A bedside approach for attendings and trainees.
Hepatocyte enzymes: ALT, AST
DOTake a drug, alcohol, and viral-risk history. Trend the values, don't react to a single number.
Cholestasis markers: ALP, GGT, bilirubin
DOIf obstruction is on the table, get a right upper quadrant POCUS.
Synthetic function: albumin, INR
DOStage the severity. Synthetic failure changes disposition, not just the differential.
The one line to remember
ALT and AST measure damage. Albumin and INR measure function. A cirrhotic liver can show near-normal enzymes and still be failing, so always finish with Question 3.
Two pearls worth the detour
Hepatic steatosis on imaging plus at least one cardiometabolic risk factor (raised BMI or waist circumference, dysglycemia, hypertension, high triglycerides, low HDL), with no significant alcohol use or other cause. The rename from NAFLD isn't cosmetic: the diagnosis is now positive (metabolic criteria present) rather than a diagnosis of exclusion.
Screen in unexplained liver disease under age 40, especially with neuropsychiatric features. Start with serum ceruloplasmin (low), 24-hour urinary copper (high), and slit-lamp for Kayser-Fleischer rings.
Lab clue: in acute Wilsonian liver failure, a disproportionately low ALP against a very high bilirubin (low ALP:bilirubin ratio), often with Coombs-negative hemolysis.